10 Micro Cap Stocks That Will Skyrocket

2. Absci Corporation (NASDAQ:ABSI)

Number of Hedge Fund Investors  in Q1 2024: 27

Date of Newsletter: June 20th

This stock, according to its pitch, is an “unknown” company that is growing revenue and trading cheaply. It is also targeting one of the biggest industries in America, healthcare, and it “could cut time to create a drug from years to days.” It has partnered up with NVIDIA and Merck, and its $5 share price at the time made it a “no-brainer.” To boot, this company is also “the world’s next big royalty business.”

So what is this ‘sure thing?’ Gumshoe says it’s the Washington based drug creation technology firm Absci Corporation (NASDAQ:ABSI). It notes that the fact that the newsletter’s publisher has invested $100,000 in this stock is comforting, and adds that Absci Corporation (NASDAQ:ABSI)’s belief that its cash can last until 2027 is quite a strong point. Key to the hypothesis is a $610 million deal with Merck, and Gumshoe cautions that over the past year or so, the timeline for these payments has been further pushed into the future.